Journal article 914 views 192 downloads
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial
Stephen C. Bain,
Ofri Mosenzon,
Rosario Arechavaleta,
Pawel Bogdański,
Abdurrahman Comlekci,
Agostino Consoli,
Chaicharn Deerochanawong,
Kathleen Dungan,
Maria C. Faingold,
Michael E. Farkouh,
Denise R. Franco,
Jeppe Gram,
Cristian Guja,
Pankaj Joshi,
Rachid Malek,
Juan F. Merino-Torres,
Michael A. Nauck,
Sue D. Pedersen,
Wayne H. -H. Sheu,
Robert J. Silver,
Cees J. Tack,
Nikhil Tandon,
Ole K. Jeppesen,
Mette Strange,
Mette Thomsen,
Mansoor Husain,
Steve Bain
Diabetes, Obesity and Metabolism
Swansea University Author: Steve Bain
-
PDF | Version of Record
Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC-ND).
Download (856.24KB)
DOI (Published version): 10.1111/dom.13553
Abstract
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial
Published in: | Diabetes, Obesity and Metabolism |
---|---|
ISSN: | 14628902 |
Published: |
2018
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa44806 |
first_indexed |
2018-10-09T15:17:39Z |
---|---|
last_indexed |
2023-01-11T14:21:35Z |
id |
cronfa44806 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-12-02T19:03:29.2067587</datestamp><bib-version>v2</bib-version><id>44806</id><entry>2018-10-09</entry><title>Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-10-09</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume/><journalNumber/><paginationStart/><paginationEnd/><publisher/><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>14628902</issnPrint><issnElectronic/><keywords/><publishedDay>31</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-12-31</publishedDate><doi>10.1111/dom.13553</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders/><projectreference/><lastEdited>2022-12-02T19:03:29.2067587</lastEdited><Created>2018-10-09T07:14:26.4972423</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Stephen C.</firstname><surname>Bain</surname><order>1</order></author><author><firstname>Ofri</firstname><surname>Mosenzon</surname><order>2</order></author><author><firstname>Rosario</firstname><surname>Arechavaleta</surname><order>3</order></author><author><firstname>Pawel</firstname><surname>Bogdański</surname><order>4</order></author><author><firstname>Abdurrahman</firstname><surname>Comlekci</surname><order>5</order></author><author><firstname>Agostino</firstname><surname>Consoli</surname><order>6</order></author><author><firstname>Chaicharn</firstname><surname>Deerochanawong</surname><order>7</order></author><author><firstname>Kathleen</firstname><surname>Dungan</surname><order>8</order></author><author><firstname>Maria C.</firstname><surname>Faingold</surname><order>9</order></author><author><firstname>Michael E.</firstname><surname>Farkouh</surname><order>10</order></author><author><firstname>Denise R.</firstname><surname>Franco</surname><order>11</order></author><author><firstname>Jeppe</firstname><surname>Gram</surname><order>12</order></author><author><firstname>Cristian</firstname><surname>Guja</surname><order>13</order></author><author><firstname>Pankaj</firstname><surname>Joshi</surname><order>14</order></author><author><firstname>Rachid</firstname><surname>Malek</surname><order>15</order></author><author><firstname>Juan F.</firstname><surname>Merino-Torres</surname><order>16</order></author><author><firstname>Michael A.</firstname><surname>Nauck</surname><order>17</order></author><author><firstname>Sue D.</firstname><surname>Pedersen</surname><order>18</order></author><author><firstname>Wayne H. -H.</firstname><surname>Sheu</surname><order>19</order></author><author><firstname>Robert J.</firstname><surname>Silver</surname><order>20</order></author><author><firstname>Cees J.</firstname><surname>Tack</surname><order>21</order></author><author><firstname>Nikhil</firstname><surname>Tandon</surname><order>22</order></author><author><firstname>Ole K.</firstname><surname>Jeppesen</surname><order>23</order></author><author><firstname>Mette</firstname><surname>Strange</surname><order>24</order></author><author><firstname>Mette</firstname><surname>Thomsen</surname><order>25</order></author><author><firstname>Mansoor</firstname><surname>Husain</surname><order>26</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>27</order></author></authors><documents><document><filename>0044806-29112018161830.pdf</filename><originalFilename>44806.pdf</originalFilename><uploaded>2018-11-29T16:18:30.0930000</uploaded><type>Output</type><contentLength>869437</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><embargoDate>2018-11-28T00:00:00.0000000</embargoDate><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC-ND).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807> |
spelling |
2022-12-02T19:03:29.2067587 v2 44806 2018-10-09 Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2018-10-09 MEDS Journal Article Diabetes, Obesity and Metabolism 14628902 31 12 2018 2018-12-31 10.1111/dom.13553 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2022-12-02T19:03:29.2067587 2018-10-09T07:14:26.4972423 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Stephen C. Bain 1 Ofri Mosenzon 2 Rosario Arechavaleta 3 Pawel Bogdański 4 Abdurrahman Comlekci 5 Agostino Consoli 6 Chaicharn Deerochanawong 7 Kathleen Dungan 8 Maria C. Faingold 9 Michael E. Farkouh 10 Denise R. Franco 11 Jeppe Gram 12 Cristian Guja 13 Pankaj Joshi 14 Rachid Malek 15 Juan F. Merino-Torres 16 Michael A. Nauck 17 Sue D. Pedersen 18 Wayne H. -H. Sheu 19 Robert J. Silver 20 Cees J. Tack 21 Nikhil Tandon 22 Ole K. Jeppesen 23 Mette Strange 24 Mette Thomsen 25 Mansoor Husain 26 Steve Bain 0000-0001-8519-4964 27 0044806-29112018161830.pdf 44806.pdf 2018-11-29T16:18:30.0930000 Output 869437 application/pdf Version of Record true 2018-11-28T00:00:00.0000000 Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC-ND). true eng |
title |
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial |
spellingShingle |
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial Steve Bain |
title_short |
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial |
title_full |
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial |
title_fullStr |
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial |
title_full_unstemmed |
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial |
title_sort |
Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial |
author_id_str_mv |
5399f4c6e6a70f3608a084ddb938511a |
author_id_fullname_str_mv |
5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain |
author |
Steve Bain |
author2 |
Stephen C. Bain Ofri Mosenzon Rosario Arechavaleta Pawel Bogdański Abdurrahman Comlekci Agostino Consoli Chaicharn Deerochanawong Kathleen Dungan Maria C. Faingold Michael E. Farkouh Denise R. Franco Jeppe Gram Cristian Guja Pankaj Joshi Rachid Malek Juan F. Merino-Torres Michael A. Nauck Sue D. Pedersen Wayne H. -H. Sheu Robert J. Silver Cees J. Tack Nikhil Tandon Ole K. Jeppesen Mette Strange Mette Thomsen Mansoor Husain Steve Bain |
format |
Journal article |
container_title |
Diabetes, Obesity and Metabolism |
publishDate |
2018 |
institution |
Swansea University |
issn |
14628902 |
doi_str_mv |
10.1111/dom.13553 |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
published_date |
2018-12-31T04:34:39Z |
_version_ |
1821288095213944832 |
score |
11.047306 |